Physician

Javid Mu'Az Baksh, DO

According to 2025 Medicare claims, Javid Baksh, DO (NPI: 1447413190) practices pain management in the Asheville, NC market, with the plurality of this provider's patient population coming from Buncombe, NC. This provider's primary affiliated billing organization is PREMIER PAIN SOLUTIONS PLLC (NPI: 1710336243; TIN: 812775629) and primary practice location at 28803-8592. Baksh is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), Southeastern Health Partners (ACO ID: A3325), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Baksh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,070 traditional Medicare patients, billed 6,217 HCPCS/CPT codes, and received $749,443 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 12,494 prescription claims across 2,360 beneficiaries totaling $765,563 in drug costs, led by Xtampza Er (Oxycodone Myristate). 2021 DME data shows 33 claims. Open Payments data shows 85 records totaling $2,420. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $154,444 to $765,563. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $30,364 to $2,303.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	599	3,218	$258,089
2016	518	2,563	$187,761
2017	1,187	10,587	$813,472
2018	1,376	22,494	$1,563,342
2019	1,970	27,879	$2,109,479
2020	1,602	20,737	$2,281,128
2021	1,662	15,098	$1,858,037
2022	1,619	9,245	$1,341,465
2023	1,123	7,741	$911,175
2024	1,070	6,217	$749,443

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	482	2,090	$154,444
2016	518	1,777	$163,791
2017	800	3,273	$312,426
2018	1,008	4,050	$319,916
2019	2,078	8,698	$569,713
2020	1,985	8,098	$494,195
2021	2,283	8,994	$551,661
2022	2,227	8,539	$569,216
2023	2,060	10,503	$617,624
2024	2,360	12,494	$765,563

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	177	260	$28,282
2016	257	394	$27,760
2017	350	690	$21,783
2018	231	514	$40,238
2019	149	522	$64,575
2020	49	193	$13,758
2021	14	33	$1,366
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	259	259	$115
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	245	286	$111
80307	Testing for presence of drug, by chemistry analyzers	390	485	$60
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	608	1,136	$59
J1100	Injection, dexamethasone sodium phosphate, 1 mg	267	1,365	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtampza Er	Oxycodone Myristate	238	6,283	$112,234
Belbuca	Buprenorphine Hcl	135	4,033	$92,831
Buprenorphine	Buprenorphine	372	10,422	$76,281
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	2,215	55,846	$61,366
Oxycontin	Oxycodone Hcl	112	2,739	$48,835

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	85	$2,420	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Javid Mu'Az Baksh, DO?

Tedicare shows public-source Medicare data for Javid Mu'Az Baksh, DO (NPI 1447413190), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Javid Mu'Az Baksh, DO have ACO affiliation data?

Javid Mu'Az Baksh, DO is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591), Southeastern Health Partners (MSSP, ACO ID A3325), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Javid Mu'Az Baksh, DO?

Javid Mu'Az Baksh, DO is linked to PREMIER PAIN SOLUTIONS PLLC (billing NPI 1710336243) in the available physician profile data.

Does Javid Mu'Az Baksh, DO have Open Payments data?

Javid Mu'Az Baksh, DO has 85 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.